Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromelain for Postoperative Recovery After Third Molar Surgery
NCT07894913Completed
- Sponsor
- Istanbul Kent University
- Start
- Jun 2024
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Randomised, open-label trial of bromelain in impacted third molar (I3M) (2 arms), sponsored by Istanbul Kent University. Primary endpoint: Facial Swelling at Day 7. Started Jun 2024; status: completed.
02
Drugs
bromelain
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on NCT07894913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07894913.